31 related articles for article (PubMed ID: 2302770)
1. Dietary Animal to Plant Protein Ratio Is Associated with Risk Factors of Metabolic Syndrome in Participants of the AHS-2 Calibration Study.
Azemati B; Rajaram S; Jaceldo-Siegl K; Haddad EH; Shavlik D; Fraser GE
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959848
[TBL] [Abstract][Full Text] [Related]
2. Animal-Protein Intake Is Associated with Insulin Resistance in Adventist Health Study 2 (AHS-2) Calibration Substudy Participants: A Cross-Sectional Analysis.
Azemati B; Rajaram S; Jaceldo-Siegl K; Sabate J; Shavlik D; Fraser GE; Haddad EH
Curr Dev Nutr; 2017 Apr; 1(4):e000299. PubMed ID: 29955699
[No Abstract] [Full Text] [Related]
3. Vegetarian dietary patterns are associated with a lower risk of metabolic syndrome: the adventist health study 2.
Rizzo NS; Sabaté J; Jaceldo-Siegl K; Fraser GE
Diabetes Care; 2011 May; 34(5):1225-7. PubMed ID: 21411506
[TBL] [Abstract][Full Text] [Related]
4. Risk factor distribution among sociodemographically diverse African American adults.
Resnicow K; Wang T; Dudley WN; Jackson A; Ahluwalia JS; Baranowski T; Braithwaite RL
J Urban Health; 2001 Mar; 78(1):125-40. PubMed ID: 11368192
[TBL] [Abstract][Full Text] [Related]
5. One state's approach to the regulation of cholesterol screening.
DeBoy JM
Public Health Rep; 1990; 105(6):584-8. PubMed ID: 2124359
[TBL] [Abstract][Full Text] [Related]
6. The yield of cholesterol screening in an urban black community.
Russell NK; Becker DM; Finney CP; Moses H
Am J Public Health; 1991 Apr; 81(4):448-51. PubMed ID: 2003622
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program.
Havas S; Bishop R; Koumjian L; Reisman J; Wozenski S
Am J Public Health; 1992 Mar; 82(3):458-61. PubMed ID: 1536371
[TBL] [Abstract][Full Text] [Related]
8. Measurement issues in cholesterol screening: an overview for nurses.
Finney CP
J Cardiovasc Nurs; 1991 Jan; 5(2):10-22. PubMed ID: 1987330
[TBL] [Abstract][Full Text] [Related]
9. Improving the quality of plasma cholesterol measurements in primary care.
Broughton PM; Bullock DG; Cramb R
Scand J Clin Lab Invest Suppl; 1990; 198():43-8. PubMed ID: 2189209
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol screening: comparative evaluation of on-site and laboratory-based measurements.
Bachorik PS; Rock R; Cloey T; Treciak E; Becker D; Sigmund W
Clin Chem; 1990 Feb; 36(2):255-60. PubMed ID: 2302770
[TBL] [Abstract][Full Text] [Related]
11. Precision of a dry-chemistry method of lipid screening.
Bowden RG; Kingery PM; Long L
Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
[TBL] [Abstract][Full Text] [Related]
12. Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method.
Bachorik PS; Bradford RH; Cole T; Frantz I; Gotto AM; Roberts K; Warnick GR; Williams OD
Clin Chem; 1989 Aug; 35(8):1734-9. PubMed ID: 2758642
[TBL] [Abstract][Full Text] [Related]
13. Reflotron performance in a community screening program: results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
Havas S; Bishop R; Koumjian L; Reisman J; Wozenski S
Am J Prev Med; 1991; 7(6):397-405. PubMed ID: 1790049
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-cholesterol analysis during screening: accuracy and reliability.
Bachorik PS; Cloey TA; Finney CA; Lowry DR; Becker DM
Ann Intern Med; 1991 May; 114(9):741-7. PubMed ID: 2012356
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the Reflotron for the determination of plasma cholesterol in capillary blood. Effect of operator variability.
Bhatnagar D; Durrington PN
Occup Med (Lond); 1993 May; 43(2):69-72. PubMed ID: 8495006
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
